Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria Patients

Background. Association between chronic spontaneous urticaria (CSU) and autoimmunity has been well documented. Autologous serum skin testing could support the autoimmune etiology of CSU, whereas it is difficult to interpret and could not be performed on antihistamine omitted patients. It was found t...

Full description

Saved in:
Bibliographic Details
Main Authors: Chattip Sripatumtong, Tunsuda Tansit, Papapit Tuchinda, Duangjit Kanistanon, Kanokvalai Kulthanan, Yuttana Srinoulprasert
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/6863682
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549132731940864
author Chattip Sripatumtong
Tunsuda Tansit
Papapit Tuchinda
Duangjit Kanistanon
Kanokvalai Kulthanan
Yuttana Srinoulprasert
author_facet Chattip Sripatumtong
Tunsuda Tansit
Papapit Tuchinda
Duangjit Kanistanon
Kanokvalai Kulthanan
Yuttana Srinoulprasert
author_sort Chattip Sripatumtong
collection DOAJ
description Background. Association between chronic spontaneous urticaria (CSU) and autoimmunity has been well documented. Autologous serum skin testing could support the autoimmune etiology of CSU, whereas it is difficult to interpret and could not be performed on antihistamine omitted patients. It was found that immunoglobulin G (IgG) autoantibodies (autoAbs) against high-affinity IgE receptor (FcεR1) were suggested as a potential trigger in the pathogenesis of CSU. Although many ELISA protocols have been developed to detect these autoAbs, they lacked validation or a reliable cut-off point. We, therefore, aimed to develop a validated ELISA with a reliable cut-off point to quantitate IgG anti-FcεR1α autoAbs for CSU. Methods. We developed an in-house ELISA to quantitate IgG anti-FcεR1α autoAbs. Sera from 233 CSU patients and 25 healthy people were used to test with ELISA. The cut-off point was obtained from the results subjected to analyze with receiver operating characteristic (ROC) analysis. ELISA was validated with 116 CSU patients and 150 healthy donors. Results. ELISA revealed that healthy people had a basal level of IgG anti-FcεR1α autoAbs, whereas their levels were significantly lower than autoAbs levels in CSU patients. ROC analysis of ELISA determined the cut-off point at 936.7 ng/ml. Our ELISA was validated and provided excellent sensitivity and specificity at 98.28% and 92.67%, respectively. Conclusion. Our ELISA could detect significant levels of IgG anti-FcεR1α autoAbs in CSU, supporting that these autoAbs were associated with CSU etiology. Our validated ELISA with the reliable cut-off point provided excellent accuracy at 95.11% (98.28% sensitivity and 92.67% specificity). Our ELISA could be an alternative test benefit for the patient who is unable to omit antihistamine treatment.
format Article
id doaj-art-f2eacd22809a498983694bd4f7af18fa
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-f2eacd22809a498983694bd4f7af18fa2025-02-03T06:12:13ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/6863682Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria PatientsChattip Sripatumtong0Tunsuda Tansit1Papapit Tuchinda2Duangjit Kanistanon3Kanokvalai Kulthanan4Yuttana Srinoulprasert5Department of ImmunologyDepartment of ImmunologyDepartment of DermatologyDepartment of ImmunologyDepartment of DermatologyDepartment of ImmunologyBackground. Association between chronic spontaneous urticaria (CSU) and autoimmunity has been well documented. Autologous serum skin testing could support the autoimmune etiology of CSU, whereas it is difficult to interpret and could not be performed on antihistamine omitted patients. It was found that immunoglobulin G (IgG) autoantibodies (autoAbs) against high-affinity IgE receptor (FcεR1) were suggested as a potential trigger in the pathogenesis of CSU. Although many ELISA protocols have been developed to detect these autoAbs, they lacked validation or a reliable cut-off point. We, therefore, aimed to develop a validated ELISA with a reliable cut-off point to quantitate IgG anti-FcεR1α autoAbs for CSU. Methods. We developed an in-house ELISA to quantitate IgG anti-FcεR1α autoAbs. Sera from 233 CSU patients and 25 healthy people were used to test with ELISA. The cut-off point was obtained from the results subjected to analyze with receiver operating characteristic (ROC) analysis. ELISA was validated with 116 CSU patients and 150 healthy donors. Results. ELISA revealed that healthy people had a basal level of IgG anti-FcεR1α autoAbs, whereas their levels were significantly lower than autoAbs levels in CSU patients. ROC analysis of ELISA determined the cut-off point at 936.7 ng/ml. Our ELISA was validated and provided excellent sensitivity and specificity at 98.28% and 92.67%, respectively. Conclusion. Our ELISA could detect significant levels of IgG anti-FcεR1α autoAbs in CSU, supporting that these autoAbs were associated with CSU etiology. Our validated ELISA with the reliable cut-off point provided excellent accuracy at 95.11% (98.28% sensitivity and 92.67% specificity). Our ELISA could be an alternative test benefit for the patient who is unable to omit antihistamine treatment.http://dx.doi.org/10.1155/2022/6863682
spellingShingle Chattip Sripatumtong
Tunsuda Tansit
Papapit Tuchinda
Duangjit Kanistanon
Kanokvalai Kulthanan
Yuttana Srinoulprasert
Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria Patients
Journal of Immunology Research
title Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria Patients
title_full Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria Patients
title_fullStr Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria Patients
title_full_unstemmed Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria Patients
title_short Development and Evaluation of an In-House ELISA to Detect Anti-FcεR1α IgG Autoantibodies in Chronic Spontaneous Urticaria Patients
title_sort development and evaluation of an in house elisa to detect anti fcεr1α igg autoantibodies in chronic spontaneous urticaria patients
url http://dx.doi.org/10.1155/2022/6863682
work_keys_str_mv AT chattipsripatumtong developmentandevaluationofaninhouseelisatodetectantifcer1aiggautoantibodiesinchronicspontaneousurticariapatients
AT tunsudatansit developmentandevaluationofaninhouseelisatodetectantifcer1aiggautoantibodiesinchronicspontaneousurticariapatients
AT papapittuchinda developmentandevaluationofaninhouseelisatodetectantifcer1aiggautoantibodiesinchronicspontaneousurticariapatients
AT duangjitkanistanon developmentandevaluationofaninhouseelisatodetectantifcer1aiggautoantibodiesinchronicspontaneousurticariapatients
AT kanokvalaikulthanan developmentandevaluationofaninhouseelisatodetectantifcer1aiggautoantibodiesinchronicspontaneousurticariapatients
AT yuttanasrinoulprasert developmentandevaluationofaninhouseelisatodetectantifcer1aiggautoantibodiesinchronicspontaneousurticariapatients